State of Wyoming’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.4K | Sell |
9,538
-10,654
| -53% | -$36.2K | ﹤0.01% | 1651 |
|
2025
Q1 | $81K | Sell |
20,192
-19,580
| -49% | -$78.5K | 0.01% | 1286 |
|
2024
Q4 | $258K | Buy |
39,772
+11,394
| +40% | +$73.9K | 0.03% | 664 |
|
2024
Q3 | $157K | Buy |
28,378
+4,507
| +19% | +$25K | 0.02% | 860 |
|
2024
Q2 | $133K | Buy |
23,871
+6,233
| +35% | +$34.8K | 0.02% | 844 |
|
2024
Q1 | $118K | Buy |
17,638
+4,753
| +37% | +$31.9K | 0.02% | 898 |
|
2023
Q4 | $118K | Buy |
12,885
+3,895
| +43% | +$35.5K | 0.02% | 885 |
|
2023
Q3 | $49.6K | Buy |
8,990
+4,358
| +94% | +$24.1K | 0.01% | 1241 |
|
2023
Q2 | $39.6K | Buy |
4,632
+2,328
| +101% | +$19.9K | 0.01% | 1216 |
|
2023
Q1 | $21.2K | Buy |
2,304
+505
| +28% | +$4.64K | 0.01% | 1410 |
|
2022
Q4 | $18.4K | Buy |
+1,799
| New | +$18.4K | 0.01% | 1387 |
|